TIM-3 is expressed on T cells, natural killer (NK) cells, and some antigen presenting cells,6 and is over expressed on most immune cells in patients with cancer.32 In cancer, TIM-3 expression on CD8+ T cells6,33 and NK cells6,34 indicates a dysfunctional, exhausted phenotype. This evidence concerns the gene HAVCR2 and cancer.